NFKB1 and cancer: In fact, evidence from cancer cell lines and human chondrocytes demonstrated the ability of celecoxib in controlling apoptosis and oxidative stress processes through a direct effect on p50 and p65 subunits of NF-kB pathway [43,77,78].